JPMorgan Chase & Co’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.06M | Buy |
207,722
+160,848
| +343% | +$7.02M | ﹤0.01% | 2290 |
|
|
2025
Q1 | $1.28M | Buy |
46,874
+9,809
| +26% | +$268K | ﹤0.01% | 3519 |
|
|
2024
Q4 | $1.49M | Sell |
37,065
-103,426
| -74% | -$4.16M | ﹤0.01% | 3568 |
|
|
2024
Q3 | $6.65M | Buy |
140,491
+95,547
| +213% | +$4.52M | ﹤0.01% | 2458 |
|
|
2024
Q2 | $1.34M | Sell |
44,944
-410,992
| -90% | -$12.3M | ﹤0.01% | 3331 |
|
|
2024
Q1 | $18.3M | Sell |
455,936
-56,310
| -11% | -$2.26M | ﹤0.01% | 1742 |
|
|
2023
Q4 | $13M | Sell |
512,246
-109,746
| -18% | -$2.79M | ﹤0.01% | 1912 |
|
|
2023
Q3 | $8.65M | Sell |
621,992
-33,979
| -5% | -$472K | ﹤0.01% | 2068 |
|
|
2023
Q2 | $15.1M | Buy |
655,971
+89,005
| +16% | +$2.05M | ﹤0.01% | 1735 |
|
|
2023
Q1 | $16.8M | Buy |
566,966
+15,443
| +3% | +$458K | ﹤0.01% | 1608 |
|
|
2022
Q4 | $13.8M | Sell |
551,523
-10,349
| -2% | -$258K | ﹤0.01% | 1692 |
|
|
2022
Q3 | $12.2M | Sell |
561,872
-41,506
| -7% | -$904K | ﹤0.01% | 1745 |
|
|
2022
Q2 | $11.9M | Buy |
603,378
+439,903
| +269% | +$8.66M | ﹤0.01% | 1755 |
|
|
2022
Q1 | $6.92M | Sell |
163,475
-17,158
| -9% | -$726K | ﹤0.01% | 2323 |
|
|
2021
Q4 | $11.5M | Buy |
180,633
+14,698
| +9% | +$933K | ﹤0.01% | 1987 |
|
|
2021
Q3 | $9.75M | Buy |
165,935
+1,500
| +0.9% | +$88.1K | ﹤0.01% | 2077 |
|
|
2021
Q2 | $7.98M | Buy |
164,435
+105,578
| +179% | +$5.12M | ﹤0.01% | 2313 |
|
|
2021
Q1 | $2.29M | Buy |
58,857
+36,771
| +166% | +$1.43M | ﹤0.01% | 3161 |
|
|
2020
Q4 | $1.37M | Buy |
+22,086
| New | +$1.37M | ﹤0.01% | 3196 |
|